{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T03:45:46Z","timestamp":1781495146145,"version":"3.54.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.contraception.2006.01.001","type":"journal-article","created":{"date-parts":[[2006,1,27]],"date-time":"2006-01-27T11:35:07Z","timestamp":1138361707000},"page":"223-228","source":"Crossref","is-referenced-by-count":144,"title":["Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 \u03bcg of ethinyl estradiol"],"prefix":"10.1016","volume":"73","author":[{"given":"Susan S.","family":"Jick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Russmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hershel","family":"Jick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2006.01.001_bib1","unstructured":"http:\/\/www.fda.gov\/cder\/drug\/infopage\/orthoevra\/default.htm."},{"key":"10.1016\/j.contraception.2006.01.001_bib2","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive","volume":"72","author":"van den Heuvedl","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2006.01.001_bib3","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"346","author":"World Health Organization","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2006.01.001_bib4","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/archinte.164.18.1965","article-title":"Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review","volume":"164","author":"Gomes","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.contraception.2006.01.001_bib5","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(95)91928-7","article-title":"Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components","volume":"346","author":"Jick","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2006.01.001_bib6","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1136\/bmj.321.7270.1190","article-title":"Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis","volume":"321","author":"Jick","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2006.01.001_bib7","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2006.01.001_bib8","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(95)91927-9","article-title":"Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception","volume":"346","author":"World Health Organization","year":"1995","journal-title":"Lancet"},{"issue":"Suppl 2","key":"10.1016\/j.contraception.2006.01.001_bib9","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0015-0282(01)03264-2","article-title":"A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra\/Evra)","volume":"77","author":"Sibai","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.contraception.2006.01.001_bib10","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1365-2125.2002.01606.x","article-title":"Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill","volume":"53","author":"Black","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.contraception.2006.01.001_bib11","series-title":"Applied regression analysis and other multivariable methods","author":"Kleinbaum","year":"1998"},{"key":"10.1016\/j.contraception.2006.01.001_bib12","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.ATV.0000087141.05044.1F","article-title":"Differential effects of oral and transdermal estrogen\/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial","volume":"23","author":"Oger","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.contraception.2006.01.001_bib13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2006.01.001_bib14","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(01)06522-9","article-title":"Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives","volume":"358","author":"Vasilakis-Scaramozza","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2006.01.001_bib15","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(94)90286-0","article-title":"Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation","volume":"344","author":"Vandenbroucke","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2006.01.001_bib16","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(98)04350-5","article-title":"Principles of epidemiologic research on adverse and beneficial drug effects","volume":"352","author":"Jick","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2006.01.001_bib17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/jech.52.12.775","article-title":"Combined oral contraceptives, smoking, and cardiovascular risk","volume":"52","author":"Farley","year":"1998","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.contraception.2006.01.001_bib18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1136\/bmj.2.6089.729","article-title":"Oral contraceptive use and venous thromboembolism: absence of an effect of smoking","volume":"2","author":"Lawson","year":"1977","journal-title":"Br Med J"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782406000084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782406000084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T15:21:58Z","timestamp":1547824918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782406000084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0010782406000084"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2006.01.001","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.14168.471549","asserted-by":"object"}]},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}